DR. JEFFREY L CONKLIN, M.D.
Osteopathic Medicine in Los Angeles, CA
License number
California C50919
Category
Medical Practice
Type
Specialist
License number
California C50919
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
8700 Beverly Blvd., Los Angeles, CA 90048
Phone
(310) 967-1884
(310) 967-1744 (Fax)
(310) 967-1744 (Fax)
Personal information
See more information about JEFFREY L CONKLIN at radaris.comName
Address
Phone
5437 E Rosebay St, Long Beach, CA 90808
4050 Valley Fair St, Simi Valley, CA 93063
8501 E Woodcove Dr APT 111, Anaheim, CA 92808
833 N Genesee Ave, Los Angeles, CA 90046
8070 Cobble Ct, Granite Bay, CA 95746
Organization information
See more information about JEFFREY L CONKLIN at bizstanding.comJeffrey L Conklin MD
100 Ucla Medical Plz, Los Angeles, CA 90024
Categories:
Physicians & Surgeons
Phone:
(310) 206-6279 (Phone)
Professional information
See more information about JEFFREY L CONKLIN at trustoria.com
Dr. Jeffrey L Conklin, Los Angeles CA - MD (Doctor of Medicine)
Dr. Jeffrey L Conklin, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
8700 Beverly Blvd, Los Angeles 90048
(310) 967-1884 (Phone), (310) 967-1744 (Fax)
(310) 967-1884 (Phone), (310) 967-1744 (Fax)
Certifications:
Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
8700 Beverly Blvd, Los Angeles 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
University of Ia Roy J & L Carver Com
Graduated: 1978
University of Ia Roy J & L Carver Com
Graduated: 1978
Jeffrey L Conklin, West Hollywood CA
Jeffrey L Conklin, West Hollywood CA
Specialties:
Internist
Address:
8700 Beverly Blvd, West Hollywood, CA 90048
100 Ucla Medical Plz, Los Angeles, CA 90024
100 Ucla Medical Plz, Los Angeles, CA 90024
Use Of Glp-1 Receptor Agonists For The Treatment Of Short Bowel Syndrome
Use Of Glp-1 Receptor Agonists For The Treatment Of Short Bowel Syndrome
US Patent:
8236760, Aug 7, 2012
Filed:
Apr 24, 2008
Appl. No.:
12/597892
Inventors:
Mark Pimentel - Los Angeles CA, US
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Assignee:
Cedars-Sinsai Medical Center - Los Angeles CA
International Classification:
A61K 38/26, A61K 38/00
US Classification:
514 72, 514 117, 530300
Abstract:
The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.
Use Of Electrical Stimulation Of The Lower Esophageal Sphincter To Modulate Lower Esophageal Sphincter Pressure
Use Of Electrical Stimulation Of The Lower Esophageal Sphincter To Modulate Lower Esophageal Sphincter Pressure
US Patent:
8160709, Apr 17, 2012
Filed:
May 14, 2007
Appl. No.:
12/300614
Inventors:
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Assignee:
Endostim, Inc. - St. Louis MO
International Classification:
A61N 1/36
US Classification:
607 40
Abstract:
The present invention describes methods and devices using low frequency electrical stimulation or neural high frequency stimulation to modulate lower esophageal sphincter (LES) pressure. The electrical stimulation may be delivered to the LES via one or more electrodes that is placed in contact with the LES tissue. The methods and devices are useful to treat a number of conditions or disease conditions, including for example, gastroesophageal reflux disease (GERD).
Systems And Methods For Electrically Stimulating The Lower Esophageal Sphincter To Treat Gastroesophageal Reflux Disease
Systems And Methods For Electrically Stimulating The Lower Esophageal Sphincter To Treat Gastroesophageal Reflux Disease
US Patent:
8538534, Sep 17, 2013
Filed:
Mar 13, 2012
Appl. No.:
13/419255
Inventors:
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Assignee:
Endostim, Inc. - St. Louis MO
International Classification:
A61N 1/36
US Classification:
607 40
Abstract:
The present specification describes methods and devices using electrical stimulation to modulate lower esophageal sphincter (LES) pressure. The electrical stimulation may be delivered to the LES via one or more electrodes that is placed in contact with the LES tissue. The methods and devices are useful to treat a number of conditions or disease conditions, including for example, gastroesophageal reflux disease (GERD).
Method, Device And System For Automatic Detection Of Eating And Drinking
Method, Device And System For Automatic Detection Of Eating And Drinking
US Patent:
2010007, Mar 25, 2010
Filed:
Nov 30, 2007
Appl. No.:
12/516770
Inventors:
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - West Hollywood CA, US
Claudia Sanmiguel - Long Beach CA, US
Jeffrey Conklin - West Hollywood CA, US
Claudia Sanmiguel - Long Beach CA, US
International Classification:
A61B 5/103
US Classification:
600587
Abstract:
A method of detecting food or drink intake in a subject by placing one or more electrodes in contact with or proximate to the subject's lower esophageal sphincter (LES), and identifying food or drink intake by monitoring electrical activity in or proximate to the LES using the one or more electrodes. The present invention also provides a device and a system for automatically detecting food or drink intake.
Use Of Glp-1 Receptor Agonists For The Treatment Of Gastrointestinal Disorders
Use Of Glp-1 Receptor Agonists For The Treatment Of Gastrointestinal Disorders
US Patent:
2012029, Nov 22, 2012
Filed:
Jul 5, 2012
Appl. No.:
13/542285
Inventors:
Mark Pimentel - Los Angeles CA, US
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Edy E. Soffer - Los Angeles CA, US
Jeffrey Conklin - Los Angeles CA, US
Assignee:
CEDARS- SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 38/26, A61P 1/06, A61P 1/00, A61K 38/16, C07K 14/46
US Classification:
514 117, 514 213, 530324
Abstract:
The present invention describes the methods of using incretin mimetics such as GLP-1 receptor agonists, particularly exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.